<DOC>
	<DOCNO>NCT00719576</DOCNO>
	<brief_summary>The objective trial investigate outcome treatment autologous chondrocytes compare microfracture technique patient symptomatic knee disease .</brief_summary>
	<brief_title>A Comparison Between Performance Chondrocytes Versus Microfracture Technique Knee Symptoms</brief_title>
	<detailed_description>This prospective , randomize , open-label , parallel-group , multicenter study design investigate outcome MACI implant versus arthroscopic microfracture treatment articular cartilage defect knee patient age 18 55 year . All patient meet eligibility criterion consider suitable inclusion cartilage biopsy take prior randomization study treatment . Eligible patient randomize index arthroscopy procedure receive either MACI implant microfracture treatment . Patients randomize treatment MACI implant return within approximately 4 8 week index arthroscopy undergo chondrocyte implantation procedure via arthrotomy . Patients randomized microfracture undergo procedure index arthroscopy . Patients assess post-arthroscopy post-arthrotomy interval 2 year follow-up . Evaluations include adverse event , functional pain outcome , arthroscopic histologic evaluation magnetic resonance imaging ( MRI ) .</detailed_description>
	<mesh_term>Cartilage Diseases</mesh_term>
	<criteria>Patients symptomatic articular cartilage defect knee . Patients surgery knee joint within 6 month prior enrollment . Patients significant malalignment . Patients instability knee . Patients majority functional meniscus absent severe osteoarthritis target knee .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Cartilage legion ,</keyword>
	<keyword>symptomatic focal cartilage defect ,</keyword>
	<keyword>microfracture ,</keyword>
	<keyword>MACI ,</keyword>
	<keyword>autologous chondrocyte</keyword>
</DOC>